Steve Oghumu1, Anna Bracewell, Uday Nori, Kirsteen H Maclean, Joan-Miquel Balada-Lasat, Sergey Brodsky, Ronald Pelletier, Mitchell Henry, Abhay R Satoskar, Tibor Nadasdy, Anjali A Satoskar. 1. 1 Department of Pathology, Ohio State University Wexner Medical Center, Columbus, Ohio. 2 Ohio State University Wexner Medical Center, Columbus, Ohio. 3 Department of Internal Medicine, Nephrology, Department of Pathology, Ohio State University Wexner Medical Center, Columbus, Ohio. 4 NanoString Technologies, Seattle, Washington. 5 Comprehensive Transplant Center, Department of Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio. 6 Address correspondence to: Anjali A. Satoskar, M,D., Department of Pathology,Division of Renal and Transplant Pathology, M015 Starling Loving, 320 W 10th Ave., Ohio State University Wexner Medical Center, Columbus, OH.
Abstract
BACKGROUND: Acute pyelonephritis (APN) versus acute rejection (AR) is a frequently encountered diagnostic and therapeutic dilemma in kidney transplants. Variable culture results, overlapping histologic features, and persistent graft dysfunction despite antibiotics are frequently encountered. Therefore, we explored the utility of intragraft microRNA profiles to distinguish between allograft APN and AR. MATERIALS AND METHODS: Between 2003 and 2011, we identified 49 patients with biopsy features of APN, within the first 2 years posttransplant. MicroRNA profiling was performed on 20 biopsies (normal kidney, n=4; unequivocal AR, n=5; features of APN, n=11). RESULTS: Only 32% (16/49) of the patients had concomitant positive urine cultures at biopsy, and in 8 of 16 patients, colony count was less than 10 CFU/mL. In 14 of 49 patients, positive urine culture did not coincide with the biopsy, and in 19 of 49 patients, urine cultures were negative. On microRNA profiling, good clustering was seen among the normal kidneys and among AR biopsies. Among the 11 biopsies with features of APN, 4 biopsies showed good clustering with a pattern distinct from AR; (these patients recovered graft function with antibiotics); 7 of 11 biopsies showed heterogeneity in microRNA profiles and variable outcomes with antibiotic treatment. We identified a panel of 25 microRNAs showing statistical difference in expression between AR and APN. MiR-99b, miR-23b let-7b-5p, miR-30a, and miR-145 were validated using qPCR. CONCLUSION: Allograft pyelonephritis can be a diagnostic and therapeutic challenge. A gestalt approach is required. In addition to histology and cultures, differential intragraft microRNA expression may prove helpful to distinguish APN from AR in renal allograft biopsies.
BACKGROUND:Acute pyelonephritis (APN) versus acute rejection (AR) is a frequently encountered diagnostic and therapeutic dilemma in kidney transplants. Variable culture results, overlapping histologic features, and persistent graft dysfunction despite antibiotics are frequently encountered. Therefore, we explored the utility of intragraft microRNA profiles to distinguish between allograft APN and AR. MATERIALS AND METHODS: Between 2003 and 2011, we identified 49 patients with biopsy features of APN, within the first 2 years posttransplant. MicroRNA profiling was performed on 20 biopsies (normal kidney, n=4; unequivocal AR, n=5; features of APN, n=11). RESULTS: Only 32% (16/49) of the patients had concomitant positive urine cultures at biopsy, and in 8 of 16 patients, colony count was less than 10 CFU/mL. In 14 of 49 patients, positive urine culture did not coincide with the biopsy, and in 19 of 49 patients, urine cultures were negative. On microRNA profiling, good clustering was seen among the normal kidneys and among AR biopsies. Among the 11 biopsies with features of APN, 4 biopsies showed good clustering with a pattern distinct from AR; (these patients recovered graft function with antibiotics); 7 of 11 biopsies showed heterogeneity in microRNA profiles and variable outcomes with antibiotic treatment. We identified a panel of 25 microRNAs showing statistical difference in expression between AR and APN. MiR-99b, miR-23b let-7b-5p, miR-30a, and miR-145 were validated using qPCR. CONCLUSION:Allograft pyelonephritis can be a diagnostic and therapeutic challenge. A gestalt approach is required. In addition to histology and cultures, differential intragraft microRNA expression may prove helpful to distinguish APN from AR in renal allograft biopsies.
Authors: Silvana Fiorante; Francisco López-Medrano; Manuel Lizasoain; Antonio Lalueza; Rafael S Juan; Amado Andrés; Joaquín R Otero; José M Morales; José M Aguado Journal: Kidney Int Date: 2010-08-18 Impact factor: 10.612
Authors: M J Scian; D G Maluf; K G David; K J Archer; J L Suh; A R Wolen; M U Mba; H D Massey; A L King; T Gehr; A Cotterell; M Posner; V Mas Journal: Am J Transplant Date: 2011-07-27 Impact factor: 8.086
Authors: Silvana Fiorante; Mario Fernández-Ruiz; Francisco López-Medrano; Manuel Lizasoain; Antonio Lalueza; José María Morales; Rafael San-Juan; Amado Andrés; Joaquín R Otero; José María Aguado Journal: Nephrol Dial Transplant Date: 2010-08-30 Impact factor: 5.992
Authors: Y Chen; Y Xiao; W Ge; K Zhou; J Wen; W Yan; Y Wang; B Wang; C Qu; J Wu; L Xu; W Cai Journal: Cell Death Dis Date: 2013-03-14 Impact factor: 8.469
Authors: Steve Oghumu; Uday Nori; Anna Bracewell; Jianying Zhang; Cherri Bott; Gyongyi M Nadasdy; Sergey V Brodsky; Ronald Pelletier; Abhay R Satoskar; Tibor Nadasdy; Anjali A Satoskar Journal: Clin Transplant Date: 2016-08-08 Impact factor: 2.863
Authors: Kristien J Ledeganck; Els M Gielis; Daniel Abramowicz; Peter Stenvinkel; Paul G Shiels; Amaryllis H Van Craenenbroeck Journal: Clin J Am Soc Nephrol Date: 2019-01-02 Impact factor: 8.237
Authors: Marta Gòdia; Louise Brogaard; Emilio Mármol-Sánchez; Rebecca Langhorn; Ida Nordang Kieler; Bert Jan Reezigt; Lise Nikolic Nielsen; Lisbeth Rem Jessen; Susanna Cirera Journal: PLoS One Date: 2022-07-20 Impact factor: 3.752